Dentro del arsenal terapéutico de la insuficiencia cardíaca, la resincronización cardíaca cada vez está adquiriendo un papel más importante como coadyuvante del tratamiento médico. Se ha demostrado ampliamente que en los pacientes con insuficiencia cardíaca avanzada y bloqueo de rama izquierda, la estimulación biventricular produce una mejoría hemodinámica y clínica, así como un remodelado inverso del ventrículo izquierdo. Algunos estudios sugieren también una disminución de la mortalidad. Sin embargo, es una terapia costosa y compleja que no está libre de complicaciones y con un porcentaje de pacientes que no mejoran. Por ello, para su correcta aplicación es necesaria una colaboración multidisciplinaria. El Grupo de Trabajo de Resincronización Cardíaca de la Sociedad Española de Cardiología ha redactado el presente documento de consenso con especial interés por exponer las indicaciones de esta terapia, así como la correcta selección de los dispositivos y su adecuada técnica de implante y seguimiento.
Palabras clave
Insuficiencia cardíaca
Marcapasos
Resincronización cardíaca
Este artículo solo puede leerse en
pdf
Bibliografía
[1.]
F. Grigioni, V. Carinci, G. Boriani, G. Bracchetti, L. Potena, G. Magnani, et al.
Accelerated QRS widening as an independent predictor of cardiac death or the need for heart transplantation in patients with congestive heart failure.
J Heart Lung Transplant, (2002), 21 pp. 899-901
[2.]
M.A. Duncan, T.D. Wait, D.G. Gibson, J.C. Daubert.
The effect of atrioventricular pacing on ejection and filling hemodynamics in patients with dilated cardiomyopathy with activation disturbances: the MUSTIC study.
J Am Coll Cardiol, (2001), 37 pp. A118
[3.]
P.A. De Teresa, J.L. Chamorro, L.A. Pulpón, C. Ruiz, I. Rodríguez Bailón, J. Alzueta, et al.
An even more physiological pacing: changing the sequence of ventricular activation. Vienna.
Proceedings, VIIth World Symposium of Cardiac Pacing, pp. 95-100
[4.]
A. Auricchio, C. Stellbrink, M. Block, S. Sack, J. Vogt, P. Bakker, et al.
Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure.
Circulation, (1999), 99 pp. 2993-3001
[5.]
W.T. Abraham, W.G. Fisher, A.L. Smith, D.B. Delurgio, A.R. Leon, E. Loh, For the MIRACLE Study Group, et al.
Cardiac resynchronization in chronic heart failure.
N Engl J Med, (2002), 346 pp. 1845-1853
[6.]
S. Cazeau, C. Leclercq, T. Lavergne, S. Walker, C. Varma, C. Linde, For the Multisite Stimulation In Cardiomyopathies (MUSTIC) Study Investigators, et al.
Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.
N Engl J Med, (2001), 344 pp. 873-880
[7.]
F. Braunschweig, C. Linde, F. Gadler, L. Rydén.
Reduction of hospital days by biventricular pacing.
Eur J Heart Fail, (2000), 2 pp. 399-406
[8.]
D.J. Bradley, E.A. Bradley, K.L. Baughman, R.D. Berger, H. Calkins, S.N. Goodman, et al.
Cardiac resynchronization and death from progressive heart failure. A meta-analysis of randomized controlled trials.
JAMA, (2003), 289 pp. 730-740
[9.]
M.R. Bristow, L.A. Saxon, J. Boehmer, S. Krueger, D.A. Kass, T. DeMarco, For the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators, et al.
Cardiacresynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
N Engl J Med, (2004), 350 pp. 2140-2150
[10.]
J.G. Cleland, J.C. Daubert, E. Erland, N. Freemantle, D. Gras, L. Kappenberger, For the Cardiac Resynchronization-Heart failure (CARE-HF)) Study Investigators, et al.
The effect of cardiac resynchronization on morbidity and mortality in heart failure.
N Engl J Med, (2005), 352 pp. 1539-1549
[11.]
G. Gregoratos, J. Abrams, A.E. Epstein, R.A. Freedman, D.L. Hayes, M.A. Hlatky, et al.
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).
Circulation, (2002), 106 pp. 2145-2161
[12.]
C.M. Yu, H. Lin, Q. Zhang, J.E. Sanderson.
High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration.
Heart, (2003), 89 pp. 54-60
[13.]
Díaz-Infante E, Mont L, Leal J, García-Bolao I, Fernández-Lozano I, Hernández-Madrid A, et al, on behalf of the Spanish Cardiac Resynchronization Study (SCARS) investigators. Clinical and echocardiographic predictors of response to resynchronization therapy. Am J Cardiol. 2005. En prensa.
[14.]
P. Sogaard, H. Egeblad, W.Y. Kim, H.K. Jensen, A.K. Pedersen, B.O. Kristensen, et al.
Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long term cardiac resynchronization therapy.
J Am Coll Cardiol, (2002), 40 pp. 723-730
[15.]
Effect of metoprolol CR/XL in chronic heart failure.
Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).
Lancet, (1999), 353 pp. 2001-2007
[16.]
A.J. Moss, W. Zareba, W.J. Hall, H.U. Klein, D.J. Wilber, D.S. Cannom, et al.
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
N Engl J Med, (2002), 346 pp. 877-883
[17.]
A.E. Buxton, K.L. Lee, J.D. Fisher, M.E. Josephson, E.N. Prystowsky, G. Hafley.
A randomized study of prevention of sudden death in patients with coronary artery disease: Multicenter Unsustained Tachycardia Trial Investigators.
N Engl J Med, (1999), 341 pp. 1882-1890
[18.]
S.E. Sandner, G. Wieselthaler, A. Zuckermann, S. Taghavi, H. Schmidinger, R. Pacher, et al.
Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation.
Circulation, (2001), 104 pp. I171-I176
[19.]
A. Kadish, A. Dyer, J.P. Daubert, R. Quigg, M. Estes, K.P. Anderson, For the Defibrillators in Non-IschemicCardiomyopathy Treatment Evaluation (DEFINITE) Investigators, et al.
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.
N Engl J Med, (2004), 350 pp. 2151-2158
[20.]
G.H. Bardy, L.L. Kerry, D.B. Mark, J.E. Poole, D.L. Packer, R. Boineau, et al.
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
N Engl J Med, (2005), 352 pp. 225-237
[21.]
S.L. Higgins, J.D. Hummel, I.K. Niazi, M.K. Giudici, S.J. Worley, L.A. Saxon, et al.
Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias.
J Am Coll Cardiol, (2003), 42 pp. 1454-1459
[22.]
J.B. Young, Wt. Abraham, A.L. Smith, A.R. Leon, R. Lieberman, B. Wilkoff, et al.
Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial.
JAMA, (2003), 289 pp. 2685-2694
[23.]
C. Alonso, C. Leclercq, F.R. D’Allonnes, D. Pavin, F. Victor, P. Mabo, et al.
Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: technical aspects.
Heart, (2001), 86 pp. 405-410
[24.]
R. Oter, J. De Juan, T. Roldán, A. Bardají, E. Molinero.
Guías de práctica clínica de la Sociedad Española de Cardiología en marcapasos.
Rev Esp Cardiol, (2000), 53 pp. 947-966
[25.]
A. Curnis, R. Neri, G. Mascioli, A.S. Cesario.
Left ventricular pacing lead choice based on coronary sinus venous anatomy.
Eur Heart J, (2000), pp. J31-J35
[26.]
D. Gras, J.P. Cebron, P. Brunel, B. Leurent, Y. Banus.
Optimal stimulation of the left ventricle.
J Cardiovasc Electrophysiol, (2002), 13 pp. S57-S62
[27.]
E.G. Daoud, S.J. Kalbfleisch, J.D. Hummel, R. Weiss, R.S. Augustini, S.B. Duff, et al.
Implantation techniques and chronic lead parameters of biventricular pacing dual-chamber defibrillators.
J Cardiovasc Electrophysiol, (2002), 13 pp. 964-970
[28.]
C. Linde, F. Gadler, M. Edner, R. Nordlander, M. Rosenqvist, L. Ryden.
Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure.
Am J Cardiol, (1995), 75 pp. 919-923
[29.]
P. Ritter, L. Padeletti, L. Gillio-Meina, G. Gaggini.
Determination of the optimal atrioventricular delay in DDD pacing. Comparison between echo and peak endocardial acceleration measurements.
Europace, (1999), 1 pp. 126-130
[30.]
Y.M. Cha, R.A. Nishimura, D.L. Hayes.
Difference in mechanical atrioventricular delay between atrial sensing and atrial pacing modes in patients with hypertrophic and dilated cardiomyopathy: an electrical hemodynamic catheterization study.
J Interv Card Electrophysiol, (2002), 6 pp. 133-140
[31.]
G.B. Perego, R. Chianca, M. Facchini, A. Frattola, E. Balla, S. Zucchi, et al.
Simultaneous vs. sequential biventricular pacing in dilated cardiomyopathy: an acute hemodynamic study.
Eur J Heart Fail, (2003), 5 pp. 305-313
[32.]
P. Sogaard, H. Egeblad, A.K. Pedersen, W.Y. Kim, B.Ø. Kristensen, P.S. Hansen, et al.
Sequential versus simultaneous biventricular resynchronization for severe heart failure: evaluation by tissue Doppler imaging.
Circulation, (2002), 106 pp. 2078-2084
[33.]
M.V. Pitzalis, M. Iacoviello, R. Romito, F. Massari, B. Rizzon, G. Luzzi, et al.
Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony.
J Am Coll Cardiol, (2002), 40 pp. 1615-1622
[34.]
J.J. Bax, T.H. Marwick, S.G. Molhoek, G.B. Bleeker, L. Van Erven, E. Boersma, et al.
Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation.
Am J Cardiol, (2003), 92 pp. 1238-1240
[35.]
A. Curnis, F. Capari, G. Mascioli, L. Bontempi, A. Scivales, F. Biancheti, et al.
Valtazione economica della reincronizzazione cardiaca nei pazienti affetti da scompenso cardiaco moderato-avanzato. Risulti dello studio BRESCIA (Biventricular RESynchronization: Cost and effectIviness Análisis).
PharmacoEconomics, (2003), 5 pp. 11-22
[36.]
A.R. Leon.
Cardiac resynchronization therapy devices: patient management and follow-up strategies.
Rev Cardiovasc Med, (2003), 4 pp. S38-S46
[37.]
C. Alonso, P. Ritter, C. Leclercq, P. Mabo, C. Bailleul, J.C. Daubert, on behalf of the MUSTIC Study Group.
Effects of cardiac resynchronization therapy on heart variability in patients with chronic systolic heart failure and intraventricular conduction delay.
Am J Cardiol, (2003), 91 pp. 1144-1147
Copyright ©
2005. Sociedad Española de Cardiología